PaxMedica (OTC: PXMD), a clinical-stage biopharmaceutical company focused on neurological disorders, has received a Notification to Grant Patent Right for…
In a significant development for the investment community, dozens of trailblazing growth companies are now listed as participating companies on…
Experts, executives, and professionals from the financial spectrum, are all invited to attend the FinovateEurope 2025 event at the Intercontinental…
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company specializing in targeted antitumor virotherapies, announced its abstract, "Development of a…
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services, announced that CEO Dr. Alan…
Adageis, a forward-thinking healthcare technology company reshaping patient care through flexible AI-centric software solutions, is in support of the Centers…
McEwen Mining (NYSE: MUX) (TSX: MUX) was highlighted in a recent article that discussed favorable positioning of the United States in…
Roth Capital Partners, LLC (“ROTH”) has announced the expansion of its sales and trading team with five seasoned professionals: Todd…
Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company focused on targeted immunotherapies, has priced its public offering of 5,000,000…
AEON Biopharma (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar pathway,…